Lipid synthesis, triggered by PPARγ T166 dephosphorylation, sustains reparative function of macrophages during tissue repair
2024 · Nature Communications · 43 citations
https://doi.org/10.1038/s41467-024-51736-5
Y
Yuxin Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
81
Citations
3
h-index
3
i10-index
Yuxin Wang is an academic researcher from Nanjing Drum Tower Hospital. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Peptidase Inhibition and Analysis & Glycosylation and Glycoproteins Research. The author has an h-index of 3, co-authored 27 publications.
ORCID: 0000-0002-3245-6665Papers by this author
worksSupplementary Table S3 from Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027916
Supplementary Table 2 from Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027922
Supplementary Figures from Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027925.v1
Supplementary Table S1 from Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027919.v1
Supplementary Table S3 from Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027916.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat